These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23303640)

  • 41. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
    Ozdemir N; Ordu S
    Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved albendazole dissolution rate in pluronic 188 solid dispersions.
    Castro SG; Bruni SS; Lanusse CE; Allemandi DA; Palma SD
    AAPS PharmSciTech; 2010 Dec; 11(4):1518-25. PubMed ID: 20945166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New binary solid dispersion of indomethacin with surfactant polymer: from physical characterization to in vitro dissolution enhancement.
    Sivert A; Bérard V; Andrès C
    J Pharm Sci; 2010 Mar; 99(3):1399-413. PubMed ID: 19827098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physicochemical reports of gliclazide-carplex solid dispersions and tablets prepared with directly compressible co-processed excipients.
    Paul S; Asha KF; Alam IZ; Ali MA; Al-Mamun ME; Rahman MBM
    Heliyon; 2023 Dec; 9(12):e22899. PubMed ID: 38076126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of novel formulations for Chagas' disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks.
    Leonardi D; Salomón CJ; Lamas MC; Olivieri AC
    Int J Pharm; 2009 Feb; 367(1-2):140-7. PubMed ID: 18938233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000.
    El-Badry M; Fetih G; Fathy M
    Saudi Pharm J; 2009 Jul; 17(3):217-25. PubMed ID: 23964164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and in vitro characterization of solid dispersion floating tablet by effervescent control release technique with improved floating capabilities.
    Singhal P; Kaushik RD; Kumar VJ; Verma A; Gupta P
    Pak J Pharm Sci; 2016 Sep; 29(5):1661-1670. PubMed ID: 27731827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
    Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
    Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV; Chotai NP; Patel MP
    Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.
    Tawfeek HM; Saleem IY; Roberts M
    J Pharm Sci; 2014 Aug; 103(8):2470-83. PubMed ID: 24995853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. To evaluate the change in release from solid dispersion using sodium lauryl sulfate and model drug sulfathiazole.
    Dave RH; Patel HH; Donahue E; Patel AD
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1562-72. PubMed ID: 23030270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers.
    Mallick S; Sahu A; Pal K
    Acta Pol Pharm; 2004; 61(1):21-30. PubMed ID: 15259854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nimesulide-modified gum karaya solid mixtures: preparation, characterization, and formulation development.
    Babu GV; Kumar NR; Himasankar K; Seshasayana A; Murthy KV
    Drug Dev Ind Pharm; 2003 Sep; 29(8):855-64. PubMed ID: 14570306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvement of solubility, dissolution and stability profile of artemether solid dispersions and self emulsified solid dispersions by solvent evaporation method.
    Tayyab Ansari M; Arshad MS; Hussain A; Ahmad Z
    Pharm Dev Technol; 2018 Dec; 23(10):1007-1015. PubMed ID: 27885872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nano-sized flake carboxymethyl cassava starch as excipient for solid dispersions.
    Lin X; Gao W; Li C; Chen J; Yang C; Wu H
    Int J Pharm; 2012 Feb; 423(2):435-9. PubMed ID: 22197771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated.
    de Waard H; Hinrichs WL; Visser MR; Bologna C; Frijlink HW
    Int J Pharm; 2008 Feb; 349(1-2):66-73. PubMed ID: 17804180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; Remon JP; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation of Solid Dispersions of Simvastatin and Soluplus Using a Single-Step Organic Solvent-Free Supercritical Fluid Process for the Drug Solubility and Dissolution Rate Enhancement.
    Nandi U; Ajiboye AL; Patel P; Douroumis D; Trivedi V
    Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and evaluation of injection-molded sustained-release tablets containing ethylcellulose and polyethylene oxide.
    Quinten T; De Beer T; Almeida A; Vlassenbroeck J; Van Hoorebeke L; Remon JP; Vervaet C
    Drug Dev Ind Pharm; 2011 Feb; 37(2):149-59. PubMed ID: 20615154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.